Camp4 Therapeutics Income Statement (2023-2026) | CAMP

Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.35M0.65M0.86M1.50M0.80M0.35M1.29M
Operating items
Research & Development (Quarter) 9.82M10.66M9.74M9.39M9.70M10.00M10.15M10.34M9.36M-29.64M10.16M
Selling, General & Administrative (Quarter) 2.87M2.81M3.13M3.27M3.81M4.69M3.81M4.18M4.60M-12.49M4.21M
Other Operating Expenses (Quarter) 0.49M55.26M
Operating Expenses (Quarter) 12.69M13.48M12.88M12.66M13.52M14.69M13.96M14.53M14.45M13.12M14.37M
Operating Income (Quarter) -12.34M-13.48M-12.88M-12.66M-13.52M-14.03M-13.10M-13.03M-13.65M-12.78M-13.07M
EBIT (Quarter) -12.34M-13.48M-12.88M-12.66M-13.52M-14.03M-13.10M-13.03M-13.65M-12.78M-13.07M
Non-operating items
Interest & Investment Income (Quarter) 0.69M0.57M0.40M0.23M0.09M0.61M0.59M0.45M0.42M0.71M0.91M
Other Non Operating Income (Quarter) 0.03M-0.14M-0.06M0.18M-0.01M-1.80M-28.03M-6.19M
Non Operating Income (Quarter) 0.64M0.49M0.42M0.09M0.03M0.76M0.67M0.44M-1.45M-27.51M-5.26M
Net income details
EBT (Quarter) -12.40M-13.37M-13.58M-13.08M-23.77M-14.29M-13.65M-20.13M-14.10M-12.94M-12.22M
Profit After Tax (Quarter) -11.70M-12.99M-12.46M-12.57M-13.48M-13.28M-12.59M-15.10M-40.28M-18.30M
Income from Continuing Operations (Quarter) -12.40M-13.37M-13.58M-13.08M-23.77M-14.29M-13.65M-20.13M-14.10M-12.94M-12.22M
Consolidated Net Income (Quarter) -12.40M-13.37M-13.58M-13.08M-23.77M-14.29M-13.65M-20.13M-14.10M-12.94M-12.22M
Income towards Parent Company (Quarter) -12.40M-13.37M-13.58M-13.08M-23.77M-14.29M-13.65M-20.13M-14.10M-12.94M-12.22M
Net Income towards Common Stockholders (Quarter) -12.40M-13.37M-13.58M-13.08M-23.77M-14.29M-13.65M-20.13M-14.10M-12.94M-12.22M
Additional items
EPS (Basic) (Quarter) -30.98-33.85-28.98-27.05-42.65-3.05-0.68-1.00-0.52-0.43-0.21
EPS (Diluted) (Quarter) -30.98-33.85-28.98-27.05-42.65-3.05-0.68-1.00-0.52-0.43-0.21
Shares Outstanding (Quarter) 0.40M0.39M0.47M0.48M0.56M4.69M20.15M20.16M27.27M30.38M57.92M
Shares Outstanding (Diluted) (Quarter) 0.40M0.39M0.47M0.48M0.56M4.69M20.15M20.16M27.27M30.38M57.92M
EBITDA (Quarter) -12.34M-13.48M-12.88M-12.66M-13.52M-14.03M-13.10M-13.03M-13.65M-12.78M-13.07M
Interest Expenses (Quarter) 0.76M0.46M1.10M0.65M10.35M0.87M1.14M7.55M0.88M0.88M0.06M